Cargando…

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates

A primary goal of HIV-1 vaccine development is the consistent elicitation of protective, neutralizing antibodies. While highly similar neutralizing antibodies (nAbs) have been isolated from multiple HIV-infected individuals, it is unclear whether vaccination can consistently elicit highly similar nA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Fangping, Chen, Wei-Hung, Wu, Weimin, Jones, Julia A., Choe, Misook, Gohain, Neelakshi, Shen, Xiaoying, LaBranche, Celia, Eaton, Amanda, Sutherland, Laura, Lee, Esther M., Hernandez, Giovanna E., Wu, Nelson R., Scearce, Richard, Seaman, Michael S., Moody, M. Anthony, Santra, Sampa, Wiehe, Kevin, Tomaras, Georgia D., Wagh, Kshitij, Korber, Bette, Bonsignori, Mattia, Montefiori, David C., Haynes, Barton F., de Val, Natalia, Joyce, M. Gordon, Saunders, Kevin O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216552/ https://www.ncbi.nlm.nih.gov/pubmed/34086838 http://dx.doi.org/10.1371/journal.ppat.1009624

Ejemplares similares

IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
por: Blasi, Maria, et al.
Publicado: (2018)

A single, continuous metric to define tiered serum neutralization potency against HIV
por: Hraber, Peter, et al.
Publicado: (2018)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022)

Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)

Polyvalent vaccine approaches to combat HIV‐1 diversity
por: Korber, Bette, et al.
Publicado: (2017)

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
por: Hraber, Peter, et al.
Publicado: (2015)

Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments
por: Hraber, Peter, et al.
Publicado: (2017)

Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
por: Blasi, Maria, et al.
Publicado: (2020)

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
por: Han, Qifeng, et al.
Publicado: (2019)

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Immune checkpoint modulation enhances HIV-1 antibody induction
por: Bradley, Todd, et al.
Publicado: (2020)

mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
por: Mu, Zekun, et al.
Publicado: (2022)

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
por: Negri, Donatella, et al.
Publicado: (2016)

Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverage
por: Wagh, Kshitij, et al.
Publicado: (2023)

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
por: Weissman, Drew, et al.
Publicado: (2021)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
por: Bradley, Todd, et al.
Publicado: (2017)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
por: Ma, Ben-Jiang, et al.
Publicado: (2011)

Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
por: Blasi, Maria, et al.
Publicado: (2020)

P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009)

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
por: Wagh, Kshitij, et al.
Publicado: (2018)

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
por: Bradley, Todd, et al.
Publicado: (2016)

Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques
por: Shen, Xiaoying, et al.
Publicado: (2017)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization
por: Han, Qifeng, et al.
Publicado: (2020)

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells
por: Jeffries, Thomas L, et al.
Publicado: (2015)

P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay
por: Bonsignori, M, et al.
Publicado: (2009)

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
por: Saunders, Kevin O., et al.
Publicado: (2021)

Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
por: Saunders, Kevin O., et al.
Publicado: (2021)

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations
por: Williams, Wilton B., et al.
Publicado: (2017)

Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
por: Seaman, Michael S., et al.
Publicado: (2020)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
por: Wee, Edmund G., et al.
Publicado: (2019)

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
por: Wee, Edmund G., et al.
Publicado: (2022)

Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
por: Dennison, S. Moses, et al.
Publicado: (2011)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2014)

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
por: Alexander, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6800tg71jl3qugp5plu6plsbc7